Paquinimod Targeting of the S100A8/A9 Axis Suppresses Liver Metastasis in Aged Mice

  • Cancers (Basel). 2026 May 19;18(10):1635. doi: 10.3390/cancers18101635.
Takao Tsuneki  1 Masafumi Saito  2 Kimihiro Yamashita  1  3 Masayuki Ando  1 Keisuke Yasuda  1 Naoto Shirakami  1 Ryota Ito  1 Yukari Adachi  1 Hiroki Kagiyama  1 Takaaki Tachibana  1 Masaki Imai  1 Sachiko Inubushi  4 Kazuki Kanayama  3 Yu-Ichiro Koma  3 Mitsugu Fujita  1  5 Joerg-Matthias Pollok  6 Yutaka Sugita  1 Taro Ikeda  1 Yasufumi Koterazawa  1 Tomoaki Aoki  1 Hitoshi Harada  1 Yasunori Otowa  1 Naoki Urakawa  1 Hironobu Goto  1 Hiroshi Hasegawa  1 Shingo Kanaji  1 Takeru Matsuda  1 Yoshihiro Kakeji  1
Affiliations
  • 1. Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Hyogo, Japan.
  • 2. Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa 359-8513, Saitama, Japan.
  • 3. Department of Biophysics, Graduate School of Health Sciences, Kobe University, Kobe 654-0142, Hyogo, Japan.
  • 4. Division of Breast Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Hyogo, Japan.
  • 5. Center for Medical Education and Clinical Training, Faculty of Medicine, Kindai University, Higashiosaka 577-8502, Osaka, Japan.
  • 6. Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London NW3 2QG, UK.
Abstract

Background: Aging profoundly alters host immunity, yet how age-associated immune changes in the liver influence the growth of metastatic tumors remains incompletely understood. Liver metastasis is a major cause of cancer-related mortality, particularly in elderly patients, for whom aggressive treatments are often not feasible. This study aimed to clarify how aging reshapes the hepatic immune microenvironment and to identify age-associated host factors that influence liver metastasis growth. Methods: Tumor-naïve and tumor-bearing young and aged mice were analyzed using a syngeneic MC38 liver metastasis model. Immune cell composition in the liver was assessed by flow cytometry, and gene expression was evaluated by quantitative Reverse transcription PCR (RT-qPCR). Public transcriptomic datasets were screened to identify age-associated inflammatory factors. The functional relevance of the S100A8/A9 axis was examined using the small-molecule inhibitor paquinimod. Results: Aging was associated with a distinct baseline immune cell composition in the liver. During liver metastasis, overall growth was comparable between young and aged mice; however, metastatic lesions in aged hosts showed increased expression of multiple inflammation-related genes and prominent accumulation of Ly6G+ cells. In silico screening identified S100a9 as one of the most highly upregulated inflammation-related genes in aged livers, which was confirmed in both tumor-naïve and metastatic liver tissues. Pharmacological modulation of the S100A8/A9 axis with paquinimod significantly reduced liver metastasis growth in aged, but not young, mice, and was accompanied by a shift in immune cell composition, including an increased representation of CD8+ T cells. Conclusions: These findings indicate that aging is associated with a distinct hepatic immune context that shapes the inflammatory and cellular composition of the tumor microenvironment during liver metastasis. S100A9 emerges as a key age-associated, host-derived factor that is functionally relevant to the growth of liver metastases in aged hosts, supporting the S100A8/A9 axis as a context-specific therapeutic target.

Keywords
CD8+ T cells; S100A8/A9 axis; aging; hepatic immune microenvironment; liver metastasis; myeloid immune cells; paquinimod.
Products